Novasp. z o.o.
Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2007-06-15. Active
32 1050 1012 1000 0090 8089 7334
44 1050 1012 1000 0090 3150 4427
22 1050 1012 1000 0090 3150 4435
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
9 public aid cases recorded, with a total value of $179,310.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 25, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,005$2,005 | Prezes Banku Gospodarstwa Krajowego | |
| May 30, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,538$2,538 | Prezes Banku Gospodarstwa Krajowego | |
| May 27, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,393$2,393 | Prezes Banku Gospodarstwa Krajowego |
Tenders
No recorded participation in tenders.
National Health Fund (NFZ) contracts
Nova has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Inne usługi realizowane w aptekach | mazowieckie | 1 | USD 0.00 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
A member of the management board independently, or a member of the management board together with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Katarzyna Elżbieta Kozioł (65) | 49 | $6,618.04 | 49% |
Piotr Ryszard Lewandowski (68) | 49 | $6,618.04 | 49% |
Others | 2 | $270.12 | 2% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2010-01-13 | PKD change (Removed: 24.42.Z, 52.31.Z, 52.32.Z, 52.33.Z, 52.42.Z, 52.48.G; Added: 21.20.Z, 32.50.Z, 47.53.Z, 47.71.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.76.Z) | |
| 2007-05-11 | Entered in the register |
FAQ
Last updated: 2026-04-14